These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Analysis of animal carcinogenicity experiments with multiple tumor types. Lu Y; Malani HM Biometrics; 1995 Mar; 51(1):73-86. PubMed ID: 7766797 [TBL] [Abstract][Full Text] [Related]
5. Estimation of k for the poly-k test with application to animal carcinogenicity studies. Moon H; Ahn H; Kodell RL; Lee JJ Stat Med; 2003 Aug; 22(16):2619-36. PubMed ID: 12898548 [TBL] [Abstract][Full Text] [Related]
7. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens? Gaylor DW Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536 [TBL] [Abstract][Full Text] [Related]
8. Global tests for analysis of multiple tumour data from animal carcinogenicity experiments. Chen JJ Stat Med; 1996 Jun; 15(11):1217-25. PubMed ID: 8804149 [TBL] [Abstract][Full Text] [Related]
9. A measure of tumorigenic potency incorporating dose-response shape. Meier KL; Bailer AJ; Portier CJ Biometrics; 1993 Sep; 49(3):917-26. PubMed ID: 8241378 [TBL] [Abstract][Full Text] [Related]
10. Constant risk differences in the analysis of animal tumorigenicity data. Dinse GE Biometrics; 1991 Jun; 47(2):681-700. PubMed ID: 1912267 [TBL] [Abstract][Full Text] [Related]
11. On the efficiency of age-adjusted tests in animal carcinogenicity experiments. Gart JJ; Tarone RE Biometrics; 1987 Mar; 43(1):235-44. PubMed ID: 3567308 [TBL] [Abstract][Full Text] [Related]
12. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
13. Modeling the effect of dose on the lifetime tumor rate from an animal carcinogenicity experiment. Finkelstein DM Biometrics; 1991 Jun; 47(2):669-80. PubMed ID: 1912266 [TBL] [Abstract][Full Text] [Related]
14. The statistical analysis of cancer inhibition/promotion experiments. Kokoska SM; Hardin JM; Grubbs CJ; Hsu C Anticancer Res; 1993; 13(5A):1357-63. PubMed ID: 8239506 [TBL] [Abstract][Full Text] [Related]
15. Ratio estimates, the delta method, and quantal response tests for increased carcinogenicity. Bieler GS; Williams RL Biometrics; 1993 Sep; 49(3):793-801. PubMed ID: 8241374 [TBL] [Abstract][Full Text] [Related]
16. Nonparametric estimation of the distribution of time to onset for specific diseases in survival/sacrifice experiments. Turnbull BW; Mitchell TJ Biometrics; 1984 Mar; 40(1):41-50. PubMed ID: 6733233 [TBL] [Abstract][Full Text] [Related]
17. "Just Another Statistic". Machtay M; Glatstein E Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105 [TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019 [TBL] [Abstract][Full Text] [Related]
19. A strategy to discover genes that carry multi-allelic or mono-allelic risk for common diseases: a cohort allelic sums test (CAST). Morgenthaler S; Thilly WG Mutat Res; 2007 Feb; 615(1-2):28-56. PubMed ID: 17101154 [TBL] [Abstract][Full Text] [Related]
20. Efficiency of age-adjusted tests in animal carcinogenicity experiments. Ryan LM Biometrics; 1985 Jun; 41(2):525-31. PubMed ID: 4027327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]